ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2020
EFFECT OF 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE DERIVATIVE ON THE COURSE OF NONALCOHOLIC FATTY LIVER DISEASE IN THE EXPERIMENT
Introduction. In the treatment of non-alcoholic fatty liver disease (NAFLD), which is the main cause of chronic liver disease, a certain role is assigned to hepatoprotectors. One of the hepatoprotectors currently used to treat NAFLD is ademetionine. At the sam…